CU20170088A7 - Formulaciones inyectables de paracetamol - Google Patents

Formulaciones inyectables de paracetamol

Info

Publication number
CU20170088A7
CU20170088A7 CUP2017000088A CU20170088A CU20170088A7 CU 20170088 A7 CU20170088 A7 CU 20170088A7 CU P2017000088 A CUP2017000088 A CU P2017000088A CU 20170088 A CU20170088 A CU 20170088A CU 20170088 A7 CU20170088 A7 CU 20170088A7
Authority
CU
Cuba
Prior art keywords
paracetamol
injectable formulations
administration
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
CUP2017000088A
Other languages
English (en)
Spanish (es)
Inventor
Prakashchandra J Ahah
Asheel K Patel
Ketan R Patel
Milan R Patel
Original Assignee
Troikaa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55022620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU20170088(A7) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Troikaa Pharmaceuticals Ltd filed Critical Troikaa Pharmaceuticals Ltd
Publication of CU20170088A7 publication Critical patent/CU20170088A7/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CUP2017000088A 2014-12-20 2015-11-17 Formulaciones inyectables de paracetamol CU20170088A7 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN4102MU2014 2014-12-20
PCT/IB2015/058876 WO2016097899A1 (en) 2014-12-20 2015-11-17 Injectable formulations of paracetamol

Publications (1)

Publication Number Publication Date
CU20170088A7 true CU20170088A7 (es) 2018-03-13

Family

ID=55022620

Family Applications (1)

Application Number Title Priority Date Filing Date
CUP2017000088A CU20170088A7 (es) 2014-12-20 2015-11-17 Formulaciones inyectables de paracetamol

Country Status (28)

Country Link
US (1) US20180000940A1 (zh)
EP (1) EP3233055A1 (zh)
JP (1) JP2017538762A (zh)
KR (1) KR20170099911A (zh)
CN (1) CN107205924A (zh)
AR (1) AR103188A1 (zh)
AU (1) AU2015365533A1 (zh)
BR (1) BR112017012975B1 (zh)
CA (1) CA2969303A1 (zh)
CL (1) CL2017001629A1 (zh)
CO (1) CO2017006268A2 (zh)
CU (1) CU20170088A7 (zh)
DO (1) DOP2017000134A (zh)
EA (1) EA201791409A1 (zh)
EC (1) ECSP17038668A (zh)
IL (1) IL252729A0 (zh)
JO (1) JO3689B1 (zh)
MA (1) MA40599A1 (zh)
MD (1) MD20170071A2 (zh)
MX (1) MX2017008264A (zh)
PE (1) PE20171305A1 (zh)
PH (1) PH12017501005A1 (zh)
SG (1) SG11201704435PA (zh)
TN (1) TN2017000232A1 (zh)
TW (1) TWI649097B (zh)
UA (1) UA122136C2 (zh)
UY (1) UY36466A (zh)
WO (1) WO2016097899A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107229455B (zh) 2016-03-24 2019-09-17 阿里巴巴集团控股有限公司 一种业务处理方法、装置及系统

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
IT1301976B1 (it) * 1998-07-31 2000-07-20 Angelini Ricerche Spa Composizione farmaceutica iniettabile a base di paracetamolo
IT1313579B1 (it) 1999-07-30 2002-09-09 Acraf Composizione farmaceutica liquida a base di paracetamolo.
ITMI20012135A1 (it) 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
MX2007014862A (es) * 2005-05-27 2008-02-21 Panacea Biotec Ltd Composiciones inyectables y procedimiento para la preparacion de dichas composiciones.
DK1973527T3 (da) * 2005-12-15 2010-02-01 Acusphere Inc Fremgangsmåder til fremstilling af partikelbaserede farmaceutiske formulationer til parenteral indgivelse
EP2170313A2 (en) 2007-06-18 2010-04-07 Combino Pharm, S.L. Aqueous formulations of acetaminophen for injection
WO2009098716A2 (en) 2008-01-17 2009-08-13 Aptuit Laurus Private Limited Stable pharmaceutical aqueous compositions
CN102159184B (zh) * 2008-10-09 2013-09-04 方济各安吉利克化学联合股份有限公司 含有对乙酰氨基酚的液体药物制剂
BR112012031928B1 (pt) 2010-06-30 2021-08-31 Troikaa Pharmaceuticals Ltd Composições farmacêuticas as quais incluem paracetamol e processo para preparação do mesmo
TWI577377B (zh) * 2010-09-16 2017-04-11 Ｖｉｉｖ醫療保健公司 醫藥組合物
CN102258485A (zh) * 2011-01-11 2011-11-30 北京润德康医药技术有限公司 一种含对乙酰氨基酚的注射用制剂及其应用
CN102600068A (zh) * 2011-01-24 2012-07-25 联康药业克雷恩特塞提斯制药实验室有限责任公司 稳定即用的可注射扑热息痛制剂

Also Published As

Publication number Publication date
CA2969303A1 (en) 2016-06-23
MX2017008264A (es) 2017-10-02
CN107205924A (zh) 2017-09-26
EP3233055A1 (en) 2017-10-25
SG11201704435PA (en) 2017-06-29
WO2016097899A1 (en) 2016-06-23
ECSP17038668A (es) 2017-12-01
KR20170099911A (ko) 2017-09-01
CL2017001629A1 (es) 2018-03-16
PH12017501005A1 (en) 2017-12-11
UY36466A (es) 2016-07-29
JP2017538762A (ja) 2017-12-28
JO3689B1 (ar) 2020-08-27
TW201622703A (zh) 2016-07-01
TWI649097B (zh) 2019-02-01
MA40599A1 (fr) 2017-11-30
BR112017012975A2 (pt) 2018-02-27
TN2017000232A1 (en) 2018-10-19
IL252729A0 (en) 2017-08-31
UA122136C2 (uk) 2020-09-25
AR103188A1 (es) 2017-04-19
DOP2017000134A (es) 2017-09-15
PE20171305A1 (es) 2017-09-05
US20180000940A1 (en) 2018-01-04
MD20170071A2 (ro) 2017-09-30
AU2015365533A1 (en) 2017-07-06
BR112017012975B1 (pt) 2023-09-26
EA201791409A1 (ru) 2017-10-31
CO2017006268A2 (es) 2017-10-20

Similar Documents

Publication Publication Date Title
ZA202102906B (en) Liquid protein formulations containing viscosity-lowering agents
PE20160681A1 (es) Formulacion de premezcla de dexmedetomidina
CL2019002190A1 (es) Reducción de la viscosidad de formulaciones farmacéuticas que comprende una proteína terapéutica a una concentración de al menos 70 mg/ml, donde la proteína terapéutica no es un anticuerpo (divisional solicitud 201700984)
SG10201902915VA (en) Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
PE20181332A1 (es) Metodos de sedacion y formulacion parenteral para uso durante el tratamiento de cuidados criticos
AR098386A1 (es) Formulación para gonadotropinas
PE20170426A1 (es) Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo
CL2017001629A1 (es) Formulaciones inyectables de paracetamol.
PH12014502494A1 (en) Parenteral esmolol formulation
EA201391512A1 (ru) Твердая фармацевтическая композиция
RU2013142835A (ru) Способ лечения ишемического инсульта
CO2018002575A2 (es) Composición de estabilidad mejorada de etanercept
RU2013143983A (ru) Способ коррекции иммунной недостаточности у инфицированного вирусом лейкоза крупного рогатого скота
RU2014142874A (ru) Способ лечения похмельного синдрома у лиц, не относящихся к больным алкоголизмом
EA201600331A1 (ru) Фармацевтическая композиция в форме раствора для внутривенного и внутримышечного введения и способ ее получения
TH154084A (th) สารละลายอะเซทามิโนเฟนที่ฉีดได้สำหรับการให้ทางไขสันหลัง
AR091633A1 (es) Solucion inyectable de acetaminofen para su administracion por via espinal
TH155633A (th) สูตรผสมแบบฉีดของเอสโมลอล